Navigation Links
Genedata Expressionist 6 with New Refiner MS Capabilities Debuts at 58th ASMS Conference on Mass Spectrometry

Leading Omics Data Management Platform Advances Integration of MS with Other Key Data to Drive Real-time Interactive Life Science Research

(PRWEB) May 24, 2010 -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Expressionist 6, which is a major new release of the award-winning enterprise system for omics data management. With new Refiner MS module capabilities for direct integration with leading mass spectrometry search engines, Genedata Expressionist 6 provides a platform for real-time biomarker discovery. New predefined workflow systems and visualization enhancements are among additional features, which combine to create a highly intuitive omics analysis environment. Genedata Expressionist 6 will be demonstrated at the 58th ASMS Conference on Mass Spectrometry (May 23 - 27; Booth #1).

“Genedata Expressionist integrates easily and seamlessly with Mascot to help scientists quickly identify and characterize proteins that are potential diagnostic markers or therapeutics,” said John Cottrell, director at Matrix Science, developers of the Mascot search engine. “Moreover, this integration provides direct access to Mascot from within the Genedata Expressionist workflows, which are unusually flexible and interactive. The ability to drill down rapidly into large and complex data sets combined with confident protein identifications provides a crucial advantage to users of Genedata Expressionist.”

From Raw Expression Data to Informative Biomarkers
Genedata Expressionist, built on a highly scalable architecture, is capable of handling extremely large data sets and studies. It provides a single-point-of-access for experimental, proprietary and public data including sample information, raw and pre-processed data, and analyses results with reports and documentation. The dedicated Refiner modules for microarray and next-generation sequencing data readily extend the system beyond classical expression data to address the entire biomarker discovery and development workflow. Integrated omics data management and mapping technology support data analysis, biological interpretation, and decision making across key technologies.

The release of Genedata Expressionist 6 strengthens the power of this enterprise system for biologists and biostatisticians alike. This major new release includes Genedata Analyst™. While also available as a standalone solution, Genedata Analyst is integral to the Genedata Expressionist system. It supports hundreds of users and billions of data points per user session. Capabilities for sophisticated data analysis and visualization combine with a comprehensive set of statistical approaches and interface to third-part algorithms.

Genedata Expressionist 6 also delivers advancements to the Refiner MS module, which include:

  • New Annotation Framework with the flexibility to handle arbitrary sources and content, applies to MS/MS, 1D/2D peaks and clusters, supports multiple heterogeneous annotations per item, and delivers powerful presentation of rich annotation content.
  • Direct Search Engine Integration with online control of Mascot searches from within workflows, interactive searches with Mascot, ChemSpider, HMDB, and offline import of Mascot, SEQUEST and MetaboCard results without information loss. Using integrated consolidation of MS/MS information often improves reliability of search results.
  • Advanced Raw Data Visualizer enables significantly faster renderings, automatic m/z peak position labeling, display of 2D peak bounds in chromatogram cuts, and 1D peaks and 1D peak clusters share selection.

“This new version of Genedata Expressionist marks the ten-year anniversary of a proven industry solution that is continually developed in collaboration with commercial and academic partners,” said Dr. Othmar Pfannes, CEO of Genedata. “The refined and optimized levels of visualization and interactivity in Genedata Expressionist 6 create the foundation for a new generation of data expression and analysis, which has the potential to address a broad range of research initiatives.”

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery and life science research, which spans target, lead and biomarker discovery. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata Phylosopher, Genedata Screener, Genedata Expressionist, and Genedata Analyst™ make research data accessible and understandable, enabling scientific discovery that fights disease and improves health worldwide. Founded in 1997, Genedata is privately held, with headquarters in Basel, Switzerland, and offices in Japan, Germany and the US.

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities
2. Genedata Expressionist with New Transcriptomics Biomarker Capabilities Advances Drug Development for Personalized Medicine
3. Genedata Screener Supports Small Molecule Research at the Broad Institute of Harvard and MIT
4. Genedata and the Institute of Experimental Medicine, Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project
5. MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products
6. Genedata at HCA Announces Banner Year for Genedata Screener at Leading Pharmaceutical Companies
7. RIKEN Center for Genomics Medicine Chooses Genedata Expressionist for High Throughput Proteomics R&D
8. Evonik Extends Long-term Research & Development Partnership with Genedata
9. Bringing Statistics to Biologists - New Genedata Analyst Launches at Society of Toxicology 49th Annual Meeting
10. Genedata Announces Five-Year Agreement Extension with Kluyver Centre for Genomics of Industrial Fermentation
11. Genedata Screener 8 Advancing Analysis of HCS, HTS and Time Series Data Debuts at SBS 16th Annual Conference
Post Your Comments:
(Date:11/30/2015)... CHICAGO , Dec. 1, 2015  An interventional radiology ... according to the preliminary results of a study being presented ... North America (RSNA). ... been done for decades by interventional radiologists as a way ... performing the procedure as a means of treating obesity is ...
(Date:11/30/2015)... , Nov. 30, 2015 Harvard Apparatus ... a biotechnology company developing bioengineered organ implants for ... notification from The NASDAQ Stock Market that it ... requirements. The letter noted that as a result ... stock having exceeded $1.00 per share for more ...
(Date:11/30/2015)... , Nov. 30, 2015  Champions Oncology, Inc. (CSBR), ... services to personalize the development and use of oncology ... Executive Officer, will be presenting at the LD MICRO ... Pacific Standard Time (PST).  The conference, held at the ... Angeles, CA , will feature 200 small/micro-cap companies ...
(Date:11/30/2015)... Nov. 30, 2015  Aytu BioScience, Inc. (OTCQB: AYTU), ... related conditions, will present at two upcoming investor conferences. ... interactive real-time virtual conference, to be held December 3, ... to be held December 2 nd & 3 ... and streamed live via webcast. Josh ...
Breaking Biology Technology:
(Date:11/17/2015)... Mass. , Nov. 17, 2015 Pressure ... leader in the development and sale of broadly enabling, ... worldwide life sciences industry, today announced it has received ... its $5 million Private Placement (the "Offering"), increasing the ... $4,025,000.  One or more additional closings are expected in ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has entered ... MIT and Harvard for use of its ArxLab ... management tools. The partnership will support the institute,s ... and chemical research information internally and with external ... used for managing the Institute,s electronic laboratory notebook, ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
Breaking Biology News(10 mins):